Imunon shareholders approve increase in authorized shares to 350M and reverse split up to 1:18

Imunon, Inc.

• Authorized common shares increased from 112.5M to 350M; amendment effective July 11, 2025.
• Reverse stock split approved at board's discretion with ratio between 1:5 and 1:18; no effective date set.
• Approved issuance of shares underlying warrants from May 2025 securities purchase agreement with investors.
• Amendment to 2018 Stock Incentive Plan approved; shares available for issuance increased.
• Directors elected: Michael H. Tardugno and Dr. Donald P. Braun as Class III directors until 2028 annual meeting.